Inkjet-Printed Biosensor Offers Less-Invasive Breast Cancer Detection

Researchers have created a novel, low-cost biosensor to detect HER-2, a breast cancer biomarker in the blood, allowing for a far less-invasive diagnostic test than the current practice, a needle biopsy. Scientists combined microfluidic technology with diagnostics, including electrochemical sensors and biomarkers, into a powerful package that can give results in about 15 minutes.